MedPath

哈尔滨瀚钧现代制药有限公司

Ownership
-
Established
2013-05-03
Employees
-
Market Cap
-
Website
www.hanjunxiandai.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

27

NMPA:27

Drug Approvals

Soya Lecithin

Product Name
大豆磷脂
Approval Number
国药准字H19999582
Approval Date
Jul 2, 2024
NMPA

Clonidine Adhesive Patch

Product Name
可乐定贴片
Approval Number
国药准字H23023542
Approval Date
Mar 22, 2024
NMPA

Nitroglycerin patches（Ⅱ）

Product Name
硝酸甘油贴片(Ⅱ)
Approval Number
国药准字H23023636
Approval Date
Dec 28, 2023
NMPA

归脾丸

Approval Number
国药准字Z20174076
Approval Date
Dec 24, 2022
NMPA

八珍丸

Approval Number
国药准字Z20174077
Approval Date
Dec 24, 2022
NMPA

斑秃丸

Approval Number
国药准字Z20174075
Approval Date
Dec 24, 2022
NMPA

板蓝根颗粒

Approval Number
国药准字Z12020406
Approval Date
Nov 2, 2022
NMPA

银黄颗粒

Approval Number
国药准字Z12020408
Approval Date
Oct 8, 2022
NMPA

通宣理肺颗粒

Approval Number
国药准字Z12020766
Approval Date
Oct 8, 2022
NMPA

Ferrous Fumarate and Docusate Sadium Capsules

Product Name
富马酸亚铁多库酯钠胶囊
Approval Number
国药准字H20163385
Approval Date
Oct 19, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.